Track topics on Twitter Track topics that are important to you
The FDA has approved Obalon Therapeutics' premarket approval supplement application for the Obalon Touch Inflation System, an -More-
Obalon Therapeutics (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obes...
Obalon Therapeutics has closed a private placement of 5.5 million shares of common stock, raising $10 million in aggregate gr -More-
Obalon Therapeutics Inc. (devices for weight loss) grossed $10mm in a private placement of 5.5mm common shares at $1.82 (a 3% premium) to institutional investors, company management and board members,...
SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled ...
SAN DIEGO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
A private placement deal involving 5.5 million shares has been reached by San Diego-based weight loss device maker Obalon The -More-
ALDEX GS™ Tablets
ALDEX GS DMTablets
To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.
Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...
Retrospective study of the data reported in the Obalon US Commercial Registry
The Obalon Balloon System - Post-Approval Study is a prospective, observational, and multi-center study.
The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...
Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System
The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...
Obalon is a private medical technology company based in San Diego, California focused on developing innovative, high-quality gastric balloon technology for weight loss therapy. ww...
Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...
Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...
Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...
Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeuticsâ¢ solutions to benefit people with unmet medical needs through cognitive and neurobehavi...
We have published hundreds of Obalon Therapeutics, Inc. news stories on BioPortfolio along with dozens of Obalon Therapeutics, Inc. Clinical Trials and PubMed Articles about Obalon Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Obalon Therapeutics, Inc. Companies in our database. You can also find out about relevant Obalon Therapeutics, Inc. Drugs and Medications on this site too.